logo
15% of women under 40 say they would likely try Botox. Is the 'preventative' messaging working?

15% of women under 40 say they would likely try Botox. Is the 'preventative' messaging working?

Yahoo06-06-2025
Botox has traditionally been sought out by older women looking to do something about the wrinkles they already have. But that's changing. Now younger women are turning to the cosmetic treatment to avoid getting those fine lines in the first place.
That's the idea behind preventative Botox, which Houston plastic surgeon Dr. Kristy Hamilton has seen explode in popularity over the past five years. 'The summer of 2020 was when I started seeing younger patients coming in and asking about starting Botox to prevent lines,' Hamilton tells Yahoo Life. 'What I tell them is that when you start to see lines linger when you're not moving your face, that's a good indicator that it's a good time to do so.'
Data from the 2023 American Society of Plastic Surgeons report indicated that while patients between the ages of 40 and 54 account for the largest percentage of those getting Botox, treatments among patients from 18 to 39 years old have been increasing. 'Many in Gen Z are starting preventative Botox, known by some as 'Baby Botox,' to stop wrinkles before they form,' the report reads.
Results from a recent Yahoo News/YouGov poll align with those findings. Among 1,677 U.S. adults surveyed in late March, 15% of women ages 18 to 39 said they would likely try Botox, compared with just 10% of women age 40 and older. This, experts say, indicates that the messaging behind preventative Botox — that when it comes to wrinkles, the best defense is a good offense — is not only spreading but also successfully convincing more people to start Botox sooner rather than later. But not everybody is buying in.
Christine Cambus, a 36-year-old makeup artist living in New York, is someone who hopped on the Baby Botox train before it was a bigger trend. In her mid-20s, she started noticing expression lines in her forehead that weren't going away. 'When I turned 26, I decided to start doing Botox because I was like, I want to get ahead of this problem before it gets more intense,' she tells Yahoo Life. 'Now here we are 10 years later and — not to toot my own horn — but people routinely think I'm still in my early to mid-20s.'
Baby Botox, aka micro-toxing, refers to using smaller doses of the neurotoxin (which isn't always Botox brand) to temporarily paralyze muscles in the face. According to Hamilton, these dosage amounts vary. 'It's still customized on the patient because I'm assessing the intensity of their muscle movement, which is going to be different person to person just based on anatomy, age, all of that,' she says. 'What we're talking about is just less than a full [Botox] treatment … usually less than half of what is recommended by the pharmaceutical companies.'
Cambus receives 30 units for the injections across her forehead. 'I get it up into my hairline,' she says. 'I get my 11's and the very outward edges of my eyebrows because I want my brows to kind of tick up a bit at the end.' She believes that the injections she's had over the years are the reason she hasn't developed lines elsewhere, like crow's-feet.
Hamilton backs this up. 'It's preventing the lines that are caused by movement, so if she's getting a little bit around the corners of the eyes, that's what is preventing her crow's-feet wrinkles,' she says. But if Cambus were only injecting the 11's between her eyebrows, for example, it wouldn't have that same preventative effect on the outside of the eyes.
Jess Peachy, a 26-year-old from Charlotte, N.C., on the other hand, has been interested in getting injected since first hearing about preventative Botox on Bravo shows like Vanderpump Rules. But she has decided against it after doing further research.
'I looked into it, looked at other people's TikTok videos about their experiences and everything seemed fine and seemed good and normal. Everyone was like, 'My face isn't moving, I'm not getting wrinkles,'' she tells Yahoo Life. 'But what changed my mind about getting it was when people had masseter Botox and started discussing that after a while, they got the jowls.'
Peachy is referring to people having Botox injections in their masseter muscle along the jaw — not an area prone to wrinkling — and experiencing jowl-like drooping. Peachy worries that sort of effect could happen elsewhere on her face if she tried Botox. 'At the end of the day, it is weakening your muscles, so I'm afraid of putting it in my face and the long-term effects of it,' she says. 'I don't want any muscle atrophy and to end up with loose and saggy skin.'
Dr. Sean McNally, a plastic surgeon in Oregon, tells Yahoo Life that there is a slight possibility of experiencing significant weakening. But he says it's rare for people to be getting so much Botox so frequently to get to that point.
'If people are very consistently, very aggressively high-dosing Botox in certain muscles, and if they do that for years, those muscles can actually look weak and anemic, kind of pink instead of red. They do weaken with time,' he says.
But McNally adds: 'For most people, they are not redosing their Botox before their Botox has completely worn off. So they're going to have this break in between where the muscle is functioning and you're actually using it for a while and then redosing it. It's not a long-term concern because if somebody is dosing you appropriately, they're going to be weakening the muscles but not completely freezing them out.'
McNally himself has been getting injections for 12 years, starting when he was 31. If he hadn't gone the preventative route, he says, 'I would now have permanent creases that even with Botox wouldn't go away.'
The messaging of preventative botox is working when it comes to getting younger people interested and considering it. What was previously a part of beauty regimens and culture for older women is now 'just something that Gen Z talks about,' says Hamilton. But that doesn't necessarily mean that every young person is running to get it. For some, it's concerns about the long-term effects holding them back; for others, it's the price tag.
For those who are eager to begin, McNally encourages patients to wait until they're 25. 'I don't think you're going to get a ton of benefit out of it until you're in your late 20s, early 30s,' he says, unless there's an otherwise significant indication (like a skin or collagen condition) that someone younger should be starting.
Hamilton recommends that people of all ages be particular when selecting who is doing the injection. That's especially important for young patients who don't want to overdo it. 'It's about going to someone that matches your aesthetic or understands your aesthetic,' she says. 'So if you walk into the office and everyone is completely frozen and people don't have any movement, that's probably not the office for you.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How will Trump's E.U. tariffs affect drug prices?
How will Trump's E.U. tariffs affect drug prices?

Yahoo

time7 hours ago

  • Yahoo

How will Trump's E.U. tariffs affect drug prices?

President Donald Trump's trade deal with the European Union may lead to higher prices for brand-name drugs in the United States, including blockbuster medications like Ozempic and Wegovy, experts say. The trade deal, announced Sunday, places a 15% tariff on most imported goods from the E.U., including pharmaceuticals. While that comes in well below the 200% tariffs Trump had threatened on pharmaceutical imports earlier this month, it'll still have an impact. Pharmaceuticals are the United States' fifth largest import, said Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School. Europe is a major manufacturing hub for brand-name drugs in particular. Nearly half of the active ingredients for brand-name drugs taken in the United States are produced in European countries such as Ireland, Germany, Italy and Belgium, Kesselheim said. Europe is also where many drugmakers do final steps, such as filling and packaging. Novo Nordisk's diabetes and obesity drugs Ozempic and Wegovy are both produced in Denmark. Botox, made by Allergen, and the cancer drug Keytruda from drugmaker Merck are made in Ireland. (In recent years, however, more of Keytruda's manufacturing has shifted to the United States.) While brand-name drugs only account for about 10% of prescriptions filled in the United States, they make up about 80% of all drug spending, Kesselheim said. 'That's because they're priced so high,' he said. 'Each individual [generic] statin is pennies, whereas Botox is thousands to tens of thousands of dollars.' In the short term, drug companies might increase the list prices of these products to account for the higher cost, said Rena Conti, an associate professor at Boston University's Questrom School of Business. 'U.S. consumers will pay more at the pharmacy counter for these drugs,' Conti said. 'What patients pay at the pharmacy counter reflects drug companies' set price list.' Kesselheim said it's an open question whether patients would even notice the higher prices, given that brand-name drugs are already so expensive. 'The drug prices are already two to three times higher in the United States than they are in other countries,' he said. 'There is a lot more room for drug companies [to charge more.]' Generic drugs, on the other hand, are often sold at close to the cost that they're made. About 9 out of 10 prescription drugs taken in the United States are generics, Kesselheim added. The Pharmaceutical Research and Manufacturers of America, a drug industry trade group, did not immediately respond to a request for comment. The E.U. tariffs aren't expected to affect the prices of many generic drugs. Some generic drugs are made in Europe, but the majority are manufactured in countries like China and India, said Arthur Caplan, the head of the division of medical ethics at NYU Langone Medical Center in New York City. There have been concerns that tariffs on these countries could ​drive up the cost of generic drugs and exacerbate drug shortages. Generic drugs aren't a lucrative enough business for companies to invest in new manufacturing facilities in the United States, Caplan said. A spokesperson for the Association for Accessible Medicines, a trade group that represents generic drugmakers, said the group is still assessing the potential impact of the tariffs as well as the specifics of the trade deal. This article was originally published on Se produjo un error al recuperar la información Inicia sesión para acceder a tu portafolio Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información

How will Trump's E.U. tariffs affect drug prices?
How will Trump's E.U. tariffs affect drug prices?

NBC News

time9 hours ago

  • NBC News

How will Trump's E.U. tariffs affect drug prices?

President Donald Trump's trade deal with the European Union may lead to higher prices for brand-name drugs in the United States, including blockbuster medications like Ozempic and Wegovy, experts say. The trade deal, announced Sunday, places a 15% tariff on most imported goods from the E.U., including pharmaceuticals. While that comes in well below the 200% tariffs Trump had threatened on pharmaceutical imports earlier this month, it'll still have an impact. Pharmaceuticals are the United States' fifth largest import, said Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School. Europe is a major manufacturing hub for brand-name drugs in particular. Nearly half of the active ingredients for brand-name drugs taken in the U.S. are produced in European countries such as Ireland, Germany, Italy and Belgium, Kesselheim said. Europe is also where many drugmakers do final steps, such as filling and packaging. Novo Nordisk's diabetes and obesity drugs Ozempic and Wegovy are both produced in Denmark. Botox, made by Allergen, and the cancer drug Keytruda from drugmaker Merck are made in Ireland. (In recent years, however, more of Keytruda's manufacturing has shifted to the U.S.) While brand-name drugs only account for about 10% of prescriptions filled in the U.S., they make up about 80% of all drug spending, Kesselheim said. 'That's because they're priced so high,' he said. 'Each individual [generic] statin is pennies, whereas Botox is thousands to tens of thousands of dollars.' In the short term, drug companies might increase the list prices of these products to account for the higher cost, said Rena Conti, an associate professor at Boston University's Questrom School of Business. 'U.S. consumers will pay more at the pharmacy counter for these drugs,' Conti said. 'What patients pay at the pharmacy counter reflects drug companies' set price list.' Kesselheim said it's an open question whether patients would even notice the higher prices, given that brand-name drugs are already so expensive. 'The drug prices are already two to three times higher in the United States than they are in other countries,' he said. 'There is a lot more room for drug companies [to charge more.]' Generic drugs, on the other hand, are often sold at close to the cost that they're made. About 9 out of 10 prescription drugs taken in the U.S. are generics, Kesselheim added. The Pharmaceutical Research and Manufacturers of America, a drug industry trade group, did not immediately respond to a request for comment. The E.U. tariffs aren't expected to affect the prices of many generic drugs. Some generic drugs are made in Europe, but the majority are manufactured in countries like China and India, said Arthur Caplan, the head of the division of medical ethics at NYU Langone Medical Center in New York City. There have been concerns that tariffs on these countries could ​drive up the cost of generic drugs and exacerbate drug shortages. Generic drugs aren't a lucrative enough business for companies to invest in new manufacturing facilities in the U.S., Caplan said. A spokesperson for the Association for Accessible Medicines, a trade group that represents generic drugmakers, said the group is still assessing the potential impact of the tariffs as well as the specifics of the trade deal.

Mom paralyzed after Botox-like injections ‘poisoned' her body: ‘Worst decision I've ever made'
Mom paralyzed after Botox-like injections ‘poisoned' her body: ‘Worst decision I've ever made'

New York Post

time15 hours ago

  • New York Post

Mom paralyzed after Botox-like injections ‘poisoned' her body: ‘Worst decision I've ever made'

A mom who was left with partial paralysis thought she was 'slowly dying' after Botox-like injections 'poisoned' her body – and says she 'learned the cost of beauty the hard way.' Amanda Wolaver, 33, had been getting routine anti-wrinkle injections for 10 years with 'no issues' until a top-up left her with 'severe' headaches. She went to the hospital the next day after waking up 'unable to move,' but a CT scan revealed 'nothing was wrong.' 9 Amanda Wolaver (right), 33, had been getting routine anti-wrinkle injections for 10 years with 'no issues' until a touch-up left her with 'severe' headaches. Amanda Wolaver / SWNS Over 16 months, her symptoms worsened – she became housebound for four months and everyday tasks like showering and doing her make-up became a struggle – and an MRI revealed that she even suffered from TIA strokes. After $30,000 in tests later, a neurologist finally diagnosed Amanda with iatrogenic botulism. The rare neuromuscular disease is caused by botulinum neurotoxins – the active ingredient in Botox. Although there is no specific treatment, Amanda is 'recovering slowly' and letting time detoxify her body. Amanda, a sales director from Goodhope, Georgia, said: 'It's almost been two years and I still don't feel normal. 9 Wolaver went to the hospital the next day after waking up 'unable to move,' but a CT scan revealed 'nothing was wrong.' Amanda Wolaver / SWNS 'Never did I think this might happen to me. 'It was the worst decision I've ever made. 'I couldn't be the mother I wanted for my three children, Landen, 16, Braxton, 11, and Havyn, 5. 'As I was essentially a vegetable, unable to move, walk, drive, or do anything I love. 'But I'm grateful for the support of my husband, Josh, 39, who was there for me. 9 Over 16 months, her symptoms worsened – she became housebound for four months and everyday tasks like showering and doing her make-up became a struggle. Amanda Wolaver / SWNS 'I want my experience to educate others about botulinum toxins. 'I learned the cost of beauty the hard way.' Amanda paid $700 to have 104 units of Dysport – a Botox alternative she had never used before – injected into her forehead, crow's feet, and eleven lines in August 2023. 'I began developing this horrible migraine and thought if I slept it off, it would go away,' she said. 'However, when I woke up the next day, I couldn't function or string sentences together.' 9 An MRI revealed that Wolaver even suffered from TIA strokes. Amanda Wolaver / SWNS Botox and Dysport are neurotoxins that block muscle contractions to rid wrinkles, and both derive from botulinum toxin. Amanda visited the hospital and was told it was 'nothing to do with the injections.' 'They told me that it was probably just a severe migraine,' she said. 'But soon, my body felt like the floor was being ripped out from underneath me and that I'd collapse. 'My dizziness became so severe that I had to take Xanax to knock me out to sleep. 'I thought I was slowly dying.' 9 After numerous of testing, a neurologist finally diagnosed Amanda with iatrogenic botulism. Amanda Wolaver / SWNS Amanda visited doctors multiple times to find a cause and underwent a heart monitor implant and spinal tap surgeries. 'They thought I had MS at one point and an autoimmune disorder,' she added. 'I underwent around 10 to 15 different MRIs, CTs and multiple procedures. 'I felt like a lab rat.' Four months after her injections, a head and neck MR also revealed that the mom suffered from multiple TIA strokes. 9 Amanda, a sales director, said, 'It's almost been two years and I still don't feel normal.' Amanda Wolaver / SWNS 'That knocked me back,' she said. 'To be told I had suffered from multiple small strokes in my brain made me think that this would eventually kill me.' Her joint pain left her struggling to formulate sentences. 'My life was essentially ruined,' Amanda said. 9 'To be told I had suffered from multiple small strokes in my brain made me think that this would eventually kill me,' she continued. Amanda Wolaver / SWNS 'I lost friends and couldn't hang out with my family, as loud noises and strong smells would trigger my dizziness. 'So I couldn't even cook my kids' dinner or clean the house.' But it wasn't until she discovered a forum of people who had suffered Botox poisoning that it 'all came together.' In March 2025, she was diagnosed with iatrogenic botulism after doctors pinned the timing and correlation of her symptoms to her Dysport injections. 9 'I've cut out caffeine, soda, and even had my breast implants taken out in April to allow my body to detoxify itself,' she continued. Amanda Wolaver / SWNS 'It was a bittersweet moment,' she said. 'But there is no cure and no promise that I will be 100 per cent back to normal.' Six months later, Amanda still suffers daily with lasting effects. She said: 'I still get the occasional dizziness and I have changed my diet completely to make sure nothing bad is going in me. 9 'But now I want to create more awareness about the dangers of botulinum neurotoxins,' Wolaver said. Amanda Wolaver / SWNS 'I've cut out caffeine, soda, and even had my breast implants taken out in April to allow my body to detoxify itself. 'I don't care about my wrinkles at all now, and I'm getting more active and able to do more things with my family. 'But now I want to create more awareness about the dangers of botulinum neurotoxins. 'Hopefully, I can help prevent this from happening to others.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store